Numinus, which specializes in psychedelic research, will study MDMA-assisted therapy on 20 people
Gordon McIntyre
Payton Nyquvest, founder and CEO of Numinus.PNG
Article content
A Vancouver psychedelics company has been granted approval from Health Canada…
